Literature DB >> 25762731

Dynamics of Human Cytomegalovirus Infection in CD34+ Hematopoietic Cells and Derived Langerhans-Type Dendritic Cells.

Roxanne Coronel1, Sachiko Takayama1, Timothy Juwono1, Laura Hertel2.   

Abstract

UNLABELLED: Acquisition of human cytomegalovirus (CMV) usually occurs by contact between contaminated bodily fluids, such as urine and saliva, and host mucosal cells. Langerhans-type dendritic cells (LC) are the only type of immune cells found in the outermost layers of the oral mucosae, where they not only provide a first line of defense against CMV but can easily be targeted by orally administered vaccines, while their bone marrow resident progenitors are important sites of virus latency. In this work, we tracked the progress of infection in CD34(+) progenitor cells, immature LC (iLC), and mature LC (mLC) exposed to the clinical-like strain TB40-BAC4 or to the vaccine strain AD169varATCC, prior to their long-term maintenance under either immature or mature conditions. We show that the genomes of both strains are efficiently maintained in CD34(+) cells during their differentiation into iLC, although this requires the presence of larger amounts of input AD169varATCC DNA. Lipopolysaccharide- and CD40 ligand-induced maturation of iLC derived from latently infected progenitors was not associated with robust viral genome replication and progeny production, while maturation of directly infected iLC increased and prolonged expression of the viral immediate early proteins. While effective replication of viral genomes from both strains occurred only in mLC, both iLC and mLC produced viral progeny, suggesting that both types of LC may contribute to CMV horizontal transmission in vivo. IMPORTANCE: Human CMV is usually acquired via the oral and nasal mucosae. Langerhans-type dendritic cells (LC) are the only type of immune cells found in the outermost layers of these tissues. Understanding how CMV interacts with LC and their hematopoietic progenitors is thus essential to develop innovative means of defense against this virus. Here we show that the genomes of a virulent and an attenuated strain of CMV are maintained in hematopoietic progenitor cells during their differentiation into immature LC and that maturation of these cells by exposure to lipopolysaccharide and CD40 ligand is not sufficient to trigger virus reactivation. While the extents of viral protein expression and genome replication were broadest in directly infected mature LC populations, similar amounts of viral progeny were detected in the supernatants of immature and mature LC, suggesting that these immune cells of the oral mucosa are likely to be important for CMV transmission within the human population.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25762731      PMCID: PMC4442541          DOI: 10.1128/JVI.00305-15

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  64 in total

1.  Mature dendritic cells infiltrate the T cell-rich region of oral mucosa in chronic periodontitis: in situ, in vivo, and in vitro studies.

Authors:  R Jotwani; A K Palucka; M Al-Quotub; M Nouri-Shirazi; J Kim; D Bell; J Banchereau; C W Cutler
Journal:  J Immunol       Date:  2001-10-15       Impact factor: 5.422

2.  Fast screening procedures for random transposon libraries of cloned herpesvirus genomes: mutational analysis of human cytomegalovirus envelope glycoprotein genes.

Authors:  U Hobom; W Brune; M Messerle; G Hahn; U H Koszinowski
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

3.  Global analysis of host cell gene expression late during cytomegalovirus infection reveals extensive dysregulation of cell cycle gene expression and induction of Pseudomitosis independent of US28 function.

Authors:  Laura Hertel; Edward S Mocarski
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

4.  Mechanisms of cytomegalovirus-mediated myelosuppression: perturbation of stromal cell function versus direct infection of myeloid cells.

Authors:  P Simmons; K Kaushansky; B Torok-Storb
Journal:  Proc Natl Acad Sci U S A       Date:  1990-02       Impact factor: 11.205

5.  Regulation of cytomegalovirus gene expression: alpha and beta promoters are trans activated by viral functions in permissive human fibroblasts.

Authors:  R R Spaete; E S Mocarski
Journal:  J Virol       Date:  1985-10       Impact factor: 5.103

Review 6.  Oral mucosal Langerhans' cells.

Authors:  A W Barrett; A T Cruchley; D M Williams
Journal:  Crit Rev Oral Biol Med       Date:  1996

7.  In vitro infection of megakaryocytes and their precursors by human cytomegalovirus.

Authors:  K Crapnell; E D Zanjani; A Chaudhuri; J L Ascensao; S St Jeor; J P Maciejewski
Journal:  Blood       Date:  2000-01-15       Impact factor: 22.113

8.  Concentration-dependent effects of foscarnet on the cell cycle.

Authors:  K Stenberg; S Skog; B Tribukait
Journal:  Antimicrob Agents Chemother       Date:  1985-12       Impact factor: 5.191

9.  Preferential suppression of myelopoiesis in normal human bone marrow cells after in vitro challenge with human cytomegalovirus.

Authors:  G K Sing; F W Ruscetti
Journal:  Blood       Date:  1990-05-15       Impact factor: 22.113

10.  Human cytomegalovirus gene expression during infection of primary hematopoietic progenitor cells: a model for latency.

Authors:  Felicia D Goodrum; Craig T Jordan; Kevin High; Thomas Shenk
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-27       Impact factor: 11.205

View more
  15 in total

1.  Latent human cytomegalovirus enhances HIV-1 infection in CD34+ progenitor cells.

Authors:  Allen Ka Loon Cheung; Yiru Huang; Hau Yee Kwok; Min Chen; Zhiwei Chen
Journal:  Blood Adv       Date:  2017-01-16

2.  Human Cytomegalovirus US28 Is Important for Latent Infection of Hematopoietic Progenitor Cells.

Authors:  Monica S Humby; Christine M O'Connor
Journal:  J Virol       Date:  2015-12-30       Impact factor: 5.103

3.  Cell Line Models for Human Cytomegalovirus Latency Faithfully Mimic Viral Entry by Macropinocytosis and Endocytosis.

Authors:  Jeong-Hee Lee; Joseph R Pasquarella; Robert F Kalejta
Journal:  J Virol       Date:  2019-10-15       Impact factor: 5.103

4.  Human cytomegalovirus G protein-coupled receptor US28 promotes latency by attenuating c-fos.

Authors:  Benjamin A Krishna; Monica S Humby; William E Miller; Christine M O'Connor
Journal:  Proc Natl Acad Sci U S A       Date:  2019-01-15       Impact factor: 11.205

5.  Human Cytomegalovirus Latency: Approaching the Gordian Knot.

Authors:  Felicia Goodrum
Journal:  Annu Rev Virol       Date:  2016-08-04       Impact factor: 10.431

6.  Polyploid giant cancer cells, stemness and epithelial-mesenchymal plasticity elicited by human cytomegalovirus.

Authors:  Zeina Nehme; Sébastien Pasquereau; Sandy Haidar Ahmad; Alain Coaquette; Chloé Molimard; Franck Monnien; Marie-Paule Algros; Olivier Adotevi; Mona Diab Assaf; Jean-Paul Feugeas; Georges Herbein
Journal:  Oncogene       Date:  2021-03-25       Impact factor: 9.867

Review 7.  New Insights Into the Molecular Mechanisms and Immune Control of Cytomegalovirus Reactivation.

Authors:  Taylor A Heald-Sargent; Eleonora Forte; Xuefeng Liu; Edward B Thorp; Michael M Abecassis; Zheng Jenny Zhang; Mary A Hummel
Journal:  Transplantation       Date:  2020-05       Impact factor: 5.385

8.  Cytomegalovirus Strain TB40/E Restrictions and Adaptations to Growth in ARPE-19 Epithelial Cells.

Authors:  Mai Vo; Alexis Aguiar; Michael A McVoy; Laura Hertel
Journal:  Microorganisms       Date:  2020-04-24

9.  Activation of Langerhans-Type Dendritic Cells Alters Human Cytomegalovirus Infection and Reactivation in a Stimulus-Dependent Manner.

Authors:  Roxanne Coronel; Desyree M Jesus; Lucia Dalle Ore; Joe S Mymryk; Laura Hertel
Journal:  Front Microbiol       Date:  2016-09-14       Impact factor: 5.640

10.  Human Cytomegalovirus miR-UL148D Facilitates Latent Viral Infection by Targeting Host Cell Immediate Early Response Gene 5.

Authors:  Chaoyun Pan; Dihan Zhu; Yan Wang; Limin Li; Donghai Li; Fenyong Liu; Chen-Yu Zhang; Ke Zen
Journal:  PLoS Pathog       Date:  2016-11-08       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.